This study reveals that SHANK3 deficiency in brain endothelial cells disrupts BBB function during the neonatal period through β-Catenin imbalance, leading to ASD-related neuronal and behavioral ...

EltaMD UV Clear, a hybrid sunscreen with high levels ... it has an SPF factor of 30 and uses non-nano zinc oxide to provide broad-spectrum protection. Both Strategist columnist Chris Black and ...

Brianna is a contributing writer for InStyle covering all things beauty. She is known for discovering the coolest niche beauty brands from around the world, really good hair day tips, and best-in ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Anglers told News 5 that dozens of ice shelters near the Catawba Island State Park shoreline last week have since left the ice. About three shanties remained on Monday. “We usually come up when ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

I couldn’t have drawn it up any better.” With the win, Clarke is the first angler to clinch their spot in the 2026 Bassmaster Classic, given he competes in the final three tournaments in ...

One longtime angler learned that lesson over the weekend, and thankfully lived to tell the tale. Brian Tetzlaff says it started as a normal winter Saturday for him and his father-in-law ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...